Summary
Highlights
Anti-government rebels in Syria discovered a massive drug factory disguised as a potato chip factory, producing millions of Captagon pills. This, along with other discoveries in military and government-controlled locations, confirmed suspicions that Bashar al-Assad was running the world's largest Captagon operation.
Captagon, originally a legal drug developed in the 1960s to promote alertness, is an amphetamine similar to Adderall but stronger. It induces feelings of productivity, euphoria, and invincibility, also staving off hunger. However, it is highly addictive with severe side effects and was banned globally in 1986. Illicit production later moved from Bulgaria to the Middle East, where its legal origins made it less stigmatized than other drugs.
After facing economic sanctions and internal protest, Assad's regime turned to Captagon production and trafficking to fund his network of allies and armed groups. His brother, Maher al-Assad, led the 4th Armored Division in large-scale Captagon manufacturing. The drug trade generated an estimated $2.4 billion annually, lining the pockets of the regime's elite and giving Assad leverage over neighboring countries struggling with addiction.
Weakened by external conflicts and internal corruption, Assad's regime collapsed in late 2024 following a rebel offensive. The new Syrian leader, from the HTS rebel group, has pledged to eradicate Captagon and has begun destroying labs. However, challenges remain as smaller-scale production may fragment and move to remote areas or neighboring countries. There's also concern about users switching to more harmful alternatives like crystal meth.